Ranjana H. Advani

Also affiliated with Stanford University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma”.

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Blood(2020)10.1182/blood.2020007400

N/A

4.5DataRank · unranked

141 citations

Hatice Savas, Andrew M. Evens, Ranjana H. Advani, Brett Alan Palmer, Barbara Pro +11 more

Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project

Blood(2021)10.1182/blood.2020010387

N/A

3.4DataRank · unranked

126 citations

Tetiana Skrypets, Monica Civallero, Michael A. Spinner, Martina Manni, Won-Seog Kim +14 more

Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30221-0

N/A

3.3DataRank · unranked

142 citations

Fangxin Hong, Richard F. Ambinder, Jonathon B. Cohen, Michael J. Robertson, Kevin A. David +12 more

Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial

The Journal of Experimental Medicine(2020)10.1084/jem.20191712

N/A

1.5DataRank · unranked

39 citations

Michael S. Khodadoust, Debra K. Czerwinski, Ole Audun Werner Haabeth, Michael P. Chu, David B. Miklos +19 more

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Blood Advances(2022)10.1182/bloodadvances.2020003971

N/A

1.1DataRank · unranked

40 citations

Steven M. Horwitz, Ranjana H. Advani, Jacob Haaber Christensen, Eva Domingo‐Doménech, Giuseppe Rossi +19 more

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1345

N/A

0.851DataRank · unranked

22 citations

Fangxin Hong, Thomas M. Habermann, Ranjana H. Advani, Randy D. Gascoyne, Thomas E. Witzig +11 more

A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis

Blood Advances(2023)10.1182/bloodadvances.2023011589

N/A

0.309DataRank · unranked

4 citations

Sarah Haebe, Debra K. Czerwinski, Erik Eckhert, Grady Day, Anuja Sathe +13 more

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up

Blood Cancer Journal(2025)10.1038/s41408-025-01329-2

N/A

0.282DataRank · unranked

5 citations

Barbara Pro, Tim Illidge, Steven M. Horwitz, Lorenz Truemper, Swaminathan P. Iyer +22 more

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015282

N/A

0.185DataRank · unranked

2 citations

Neha Mehta–Shah, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Franck Morschhauser +18 more

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

Nature(2023)10.1038/s41586-023-06903-x

N/A

0DataRank · unranked

111 citations

Mohammad Shahrokh Esfahani, Andrea Garofalo, Michael Y. Li, Cédric Rossi, Tim Flerlage +44 more

Data from MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP

(2023)10.1158/1078-0432.c.6518098.v1

N/A

0DataRank · unranked

0 citations

Raquel Malumbres, Goldi A. Kozloski, Ranjana H. Advani, Neha Talreja, Shideh Chinichian +7 more

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

Nature Communications(2025)10.1038/s41467-025-64666-7

N/A

0DataRank · unranked

2 citations

Roshia Ali, Alyssa Bouska, Dylan T. Jochum, Meghana Kesireddy, Simeon Mahov +34 more

126 | THE EARLY‐STAGE CLASSIC HODGKIN LYMPHOMA INTERNATIONAL PROGNOSTICATION INDEX (E‐HIPI): AN INDIVIDUALIZED PREDICTION MODEL UTILIZING OBJECTIVE AND CONTINUOUS VARIABLES

Hematological Oncology(2025)10.1002/hon.70093_126

N/A

0DataRank · unranked

0 citations

Angie May Rodday, Matthew J. Maurer, Jenica Upshaw, Nicholas Counsell, Sabrina Rossetti +19 more

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2020002396

N/A

0DataRank · unranked

96 citations

Promie Faruque, Neha Mehta–Shah, Venkatraman Seshan, Neval Özkaya, Shakthi Bhaskar +15 more

The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma

Cancer Cell(2021)10.1016/j.ccell.2021.08.011

N/A

0DataRank · unranked

327 citations

Bogdan Luca, Mohammad Shahrokh Esfahani, Armon Azizi, Brian J. Sworder, Barzin Y. Nabet +11 more

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Blood(2021)10.1182/blood.2021012888

N/A

0DataRank · unranked

95 citations

Daniel Reed, Ashley McCook, Jeremy Sen, Christian Barlow, Mary‐Kate Malecek +48 more

Effect of CD47 Blockade on Vascular Inflammation

New England Journal of Medicine(2021)10.1056/nejmc2029834

N/A

0DataRank · unranked

94 citations

Ryusuke Nakamoto, Brandon H Doan, Yoko Kojima, Irving L. Weissman, Ranjana H. Advani +3 more

CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS

Hematological Oncology(2021)10.1002/hon.6_2880

N/A

0DataRank · unranked

1 citations

Nathalie Fiaschi, Raquel P. Deering, Ankur Dhanik, Kamil J. Cygan, W Zhang +19 more

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Blood(2022)10.1182/blood.2022015851

N/A

0DataRank · unranked

1528 citations

Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson +68 more

CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0222

N/A

0DataRank · unranked

48 citations

Vishnu Shankar, Julian J.K. Lohmeyer, Debra K. Czerwinski, Joseph G. Schroers‐Martin, Gladys M. Rodriguez +12 more

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3261

N/A

0DataRank · unranked

30 citations

Manish R. Patel, John M. Burke, Ranjana H. Advani, Bruce D. Cheson, Jeff P. Sharman +11 more